TITLE:
Can we achieve complete remission in locally advanced unresectable Hepatocellular Carcinoma (HCC) by using Sorafenib? Case report and review of literature from Qatar
AUTHORS:
Kakil Ibrahim Rasul
KEYWORDS:
Hepatocellular Ca; Sorafenib; Chemoembolization
JOURNAL NAME:
Modern Chemotherapy,
Vol.1 No.1,
July
23,
2012
ABSTRACT: Patients with HCC continue to have a dismal prognosis, with 1-year and 3-year survival rates of 36 and 17%, respectively. This is in part related to more than two-thirds of tumors being diagnosed at advanced stages, as well as a substantial portion of patients with early HCC failing to receive potentially curative treatments. Systemic therapy for advanced unresectable HCC limited until the discovery of sorafenib, we are reporting a 53 year patient with unresectable HCC achieved complete remission clinically, radiologically and biochemically with sorafenib which is the first case report.